Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
Ricardo José Tofano,1,2 Leticia Maria Pescinni-Salzedas,1 Eduardo Federighi Baisi Chagas,2 Claudia Rucco Penteado Detregiachi,2 Elen Landgraf Guiguer,1– 3 Adriano Cressoni Araujo,1,2 Marcelo Dib Bechara,1 Claudio José Rubira,1 Sandra Maria Barbalho1– 3 1Depa...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-09-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Subjects: | |
| Online Access: | https://www.dovepress.com/association-of-metabolic-syndrome-and-hyperferritinemia-in-patients-at-peer-reviewed-article-DMSO |
| _version_ | 1797936201940860928 |
|---|---|
| author | Togfano RJ Pescinni-Salzedas LM Chagas EFB Detregiachi CRP Guiguer EL Araujo AC Bechara MD Rubira CJ Barbalho II S |
| author_facet | Togfano RJ Pescinni-Salzedas LM Chagas EFB Detregiachi CRP Guiguer EL Araujo AC Bechara MD Rubira CJ Barbalho II S |
| author_sort | Togfano RJ |
| collection | DOAJ |
| description | Ricardo José Tofano,1,2 Leticia Maria Pescinni-Salzedas,1 Eduardo Federighi Baisi Chagas,2 Claudia Rucco Penteado Detregiachi,2 Elen Landgraf Guiguer,1– 3 Adriano Cressoni Araujo,1,2 Marcelo Dib Bechara,1 Claudio José Rubira,1 Sandra Maria Barbalho1– 3 1Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Marília, São Paulo, Brazil; 2Postgraduate Program in Structural and Functional Interactions in Rehabilitation, UNIMAR, Marília, São Paulo, Brazil; 3School of Food and Technology of Marilia (FATEC), Marilia, São Paulo, BrazilCorrespondence: Sandra Maria BarbalhoDepartment of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Av. Higino Muzzi Filho 1001, Marília 15525-902, São Paulo, BrazilTel +55 14 99655-3190Email smbarbalho@gmail.comAim: To evaluate the association between parameters of hyperferritinemia (HF) and metabolic syndrome (MS) in patients at cardiovascular risk.Patients and Methods: This is a cross-sectional analytical observational study that included 269 patients who attended a cardiology unit. Biochemical and anthropometric parameters were evaluated to identify the presence of HF and MS. The presence of MS was evaluated according to NCEP ATP III. Biochemical parameters (glycemia, triglycerides, HDL-c) were assessed according to the manufacturer’s protocols. Anthropometric measurements and blood pressure measurements were made by a trained professional. The chi-square (X2) test, odds ratio, normality distribution (verified by the Kolmogorov–Smirnov test), and Levene’s test were used to analyze the variables. To evaluate the effect of MS, HF, and the interaction between MS and HF, two-way analysis of variance (ANOVA) was performed based on the homogeneity of the variances, followed by Bonferroni’s post hoc comparisons. Spearman correlation analysis was performed to evaluate the relationship between quantitative variables. A multiple linear regression model was used to analyze the effect of covariables. A logistic regression model was built to analyze the variables that contribute significantly to predict the outcome (HF) using the backward method.Results: Our results showed that 57% of men and 49.5% of women presented with MS; 44% of men and 11% of women presented with HF. The presence of MS and hypertriglyceridemia increase the probability of having HF by up to 2.1 and 1.88 times, respectively, while for male sex it is increased by 6.2 times. Patients with HF have higher values of C-reactive protein, ferritin, and transferrin saturation, regardless of the presence of MS. The linear regression analysis model indicated that the variables considered in this study explain less than 30% of the variation in ferritin and that the presence of MS in men is responsible for 22% of the variation in the probability of the occurrence of HF.Conclusion: Our results show that hyperferritinemia is closely associated with the components of MS (positive correlation with glycemia, triglycerides levels, blood pressure, and waist circumference, and negative correlation with HDL-c values) in the studied population.Keywords: cardiovascular disease, hyperferritinemia, iron overload syndrome, metabolic syndrome |
| first_indexed | 2024-04-10T18:25:59Z |
| format | Article |
| id | doaj.art-cfcc5d4839274ab1baf942cc2865493f |
| institution | Directory Open Access Journal |
| issn | 1178-7007 |
| language | English |
| last_indexed | 2024-04-10T18:25:59Z |
| publishDate | 2020-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Diabetes, Metabolic Syndrome and Obesity |
| spelling | doaj.art-cfcc5d4839274ab1baf942cc2865493f2023-02-02T05:53:03ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072020-09-01Volume 133239324857339Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular RiskTogfano RJPescinni-Salzedas LMChagas EFBDetregiachi CRPGuiguer ELAraujo ACBechara MDRubira CJBarbalho II SRicardo José Tofano,1,2 Leticia Maria Pescinni-Salzedas,1 Eduardo Federighi Baisi Chagas,2 Claudia Rucco Penteado Detregiachi,2 Elen Landgraf Guiguer,1– 3 Adriano Cressoni Araujo,1,2 Marcelo Dib Bechara,1 Claudio José Rubira,1 Sandra Maria Barbalho1– 3 1Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Marília, São Paulo, Brazil; 2Postgraduate Program in Structural and Functional Interactions in Rehabilitation, UNIMAR, Marília, São Paulo, Brazil; 3School of Food and Technology of Marilia (FATEC), Marilia, São Paulo, BrazilCorrespondence: Sandra Maria BarbalhoDepartment of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Av. Higino Muzzi Filho 1001, Marília 15525-902, São Paulo, BrazilTel +55 14 99655-3190Email smbarbalho@gmail.comAim: To evaluate the association between parameters of hyperferritinemia (HF) and metabolic syndrome (MS) in patients at cardiovascular risk.Patients and Methods: This is a cross-sectional analytical observational study that included 269 patients who attended a cardiology unit. Biochemical and anthropometric parameters were evaluated to identify the presence of HF and MS. The presence of MS was evaluated according to NCEP ATP III. Biochemical parameters (glycemia, triglycerides, HDL-c) were assessed according to the manufacturer’s protocols. Anthropometric measurements and blood pressure measurements were made by a trained professional. The chi-square (X2) test, odds ratio, normality distribution (verified by the Kolmogorov–Smirnov test), and Levene’s test were used to analyze the variables. To evaluate the effect of MS, HF, and the interaction between MS and HF, two-way analysis of variance (ANOVA) was performed based on the homogeneity of the variances, followed by Bonferroni’s post hoc comparisons. Spearman correlation analysis was performed to evaluate the relationship between quantitative variables. A multiple linear regression model was used to analyze the effect of covariables. A logistic regression model was built to analyze the variables that contribute significantly to predict the outcome (HF) using the backward method.Results: Our results showed that 57% of men and 49.5% of women presented with MS; 44% of men and 11% of women presented with HF. The presence of MS and hypertriglyceridemia increase the probability of having HF by up to 2.1 and 1.88 times, respectively, while for male sex it is increased by 6.2 times. Patients with HF have higher values of C-reactive protein, ferritin, and transferrin saturation, regardless of the presence of MS. The linear regression analysis model indicated that the variables considered in this study explain less than 30% of the variation in ferritin and that the presence of MS in men is responsible for 22% of the variation in the probability of the occurrence of HF.Conclusion: Our results show that hyperferritinemia is closely associated with the components of MS (positive correlation with glycemia, triglycerides levels, blood pressure, and waist circumference, and negative correlation with HDL-c values) in the studied population.Keywords: cardiovascular disease, hyperferritinemia, iron overload syndrome, metabolic syndromehttps://www.dovepress.com/association-of-metabolic-syndrome-and-hyperferritinemia-in-patients-at-peer-reviewed-article-DMSOmetabolic syndromehyperferritinemiairon overload syndromecardiovascular diseases |
| spellingShingle | Togfano RJ Pescinni-Salzedas LM Chagas EFB Detregiachi CRP Guiguer EL Araujo AC Bechara MD Rubira CJ Barbalho II S Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk Diabetes, Metabolic Syndrome and Obesity metabolic syndrome hyperferritinemia iron overload syndrome cardiovascular diseases |
| title | Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk |
| title_full | Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk |
| title_fullStr | Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk |
| title_full_unstemmed | Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk |
| title_short | Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk |
| title_sort | association of metabolic syndrome and hyperferritinemia in patients at cardiovascular risk |
| topic | metabolic syndrome hyperferritinemia iron overload syndrome cardiovascular diseases |
| url | https://www.dovepress.com/association-of-metabolic-syndrome-and-hyperferritinemia-in-patients-at-peer-reviewed-article-DMSO |
| work_keys_str_mv | AT togfanorj associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT pescinnisalzedaslm associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT chagasefb associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT detregiachicrp associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT guiguerel associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT araujoac associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT becharamd associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT rubiracj associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk AT barbalhoiis associationofmetabolicsyndromeandhyperferritinemiainpatientsatcardiovascularrisk |